benefit risk, quantification, pharma, Drug Safety

Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company.

At the 2014 World Drug Safety Congress Americas Susan Duke, GSK, gave a presentation on “Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company.” Download and learn: Benefit-Risk thinking and quantitative evaluation at GSK How it began Where we are now Keeping it simple (unless it’s complex) What are the right questions? Where is …